- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
Nanomedicine is a field of medicine that employs nanotechnology's knowledge and techniques to illness prevention and treatment. Nanotechnology is presently being used in the creation of novel medications in the European Union (EU), and it has been designated as a Key Enabling Technology capable of bringing new and creative medical solutions to address unmet medical needs.
Nanomedicine encompasses all nanotechnology and nanomaterials-related medical applications. The evaluation of the quality, safety, and efficacy of nanoscale materials prior to regulatory approval is a regulatory hurdle in nanomedicine.
The Europe Nanomedicine Market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2026, registering a CAGR of XX% from 2024 to 2030.
The European Nanomedicine Map, created by the EU project NANOMED, gives comprehensive insights into the existing nanomedicine community by presenting all ecosystem actors in Europe and beyond on a single chart. This reference tool intends to raise awareness, provide new networking opportunities, and spark beneficial collaborations.
NANOMED MAP enlisted the help of Hypermorgen, a Berlin-based start-up, to work on the NanoMed Map's design, implementation, and optimization. Because this feature was designed to be interactive and dynamic, all nanomedicine stakeholders are encouraged to explore the map and eventually update or add their entries.
EUNCL is a Horizon Framework Programme-funded European initiative that aims to perform and standardise pre-clinical characterisation of nanomaterials for medical purposes. The characterization platform developed by EUNCL seeks to examine all types of nanomedicines generated in the EU, in line with regulators' desire for better analytical methodologies.
The EUNCL infrastructure promotes nanomedicine innovation by giving access to a state-of-the-art trans-disciplinary testing infrastructure for fully characterising nanomedicines generated by public labs, spin-offs, and innovative SMEs.
| Sl no | Topic |
| 1 | Market Segmentation |
| 2 | Scope of the report |
| 3 | Abbreviations |
| 4 | Research Methodology |
| 5 | Executive Summary |
| 6 | Introduction |
| 7 | Insights from Industry stakeholders |
| 8 | Cost breakdown of Product by sub-components and average profit margin |
| 9 | Disruptive innovation in theIndustry |
| 10 | Technology trends in the Industry |
| 11 | Consumer trends in the industry |
| 12 | Recent Production Milestones |
| 13 | Component Manufacturing in US, EU and China |
| 14 | COVID-19 impact on overall market |
| 15 | COVID-19 impact on Production of components |
| 16 | COVID-19 impact on Point of sale |
| 17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
| 18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
| 19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
| 20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
| 21 | Product installation rate by OEM, 2023 |
| 22 | Incline/Decline in Average B-2-B selling price in past 5 years |
| 23 | Competition from substitute products |
| 24 | Gross margin and average profitability of suppliers |
| 25 | New product development in past 12 months |
| 26 | M&A in past 12 months |
| 27 | Growth strategy of leading players |
| 28 | Market share of vendors, 2023 |
| 29 | Company Profiles |
| 30 | Unmet needs and opportunity for new suppliers |
| 31 | Conclusion |
| 32 | Appendix |
© 2017-2025 Mobility Foresights Admin Pvt Ltd. All rights reserved.